426 related articles for article (PubMed ID: 25878272)
1. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.
Robertson CL; Ishibashi K; Mandelkern MA; Brown AK; Ghahremani DG; Sabb F; Bilder R; Cannon T; Borg J; London ED
J Neurosci; 2015 Apr; 35(15):5990-7. PubMed ID: 25878272
[TBL] [Abstract][Full Text] [Related]
2. [
Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
4. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.
Okita K; Petersen N; Robertson CL; Dean AC; Mandelkern MA; London ED
Neuropsychopharmacology; 2016 Nov; 41(12):2913-2919. PubMed ID: 27329684
[TBL] [Abstract][Full Text] [Related]
7. Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.
Bernedo Paredes VE; Buchholz HG; Gartenschläger M; Breimhorst M; Schreckenberger M; Werhahn KJ
PLoS One; 2015; 10(11):e0141098. PubMed ID: 26544593
[TBL] [Abstract][Full Text] [Related]
8. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
9. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
10. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM
Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883
[TBL] [Abstract][Full Text] [Related]
11. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
[TBL] [Abstract][Full Text] [Related]
13. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
14. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal and striatal dopamine D
Pfeifer P; Sebastian A; Buchholz HG; Kaller CP; Gründer G; Fehr C; Schreckenberger M; Tüscher O
Brain Imaging Behav; 2022 Feb; 16(1):186-198. PubMed ID: 34403039
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal administration of botulinum neurotoxin A normalizes striatal D
Wedekind F; Oskamp A; Lang M; Hawlitschka A; Zilles K; Wree A; Bauer A
J Neurosci Res; 2018 Jan; 96(1):75-86. PubMed ID: 28695985
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.
Ghahremani DG; Lee B; Robertson CL; Tabibnia G; Morgan AT; De Shetler N; Brown AK; Monterosso JR; Aron AR; Mandelkern MA; Poldrack RA; London ED
J Neurosci; 2012 May; 32(21):7316-24. PubMed ID: 22623677
[TBL] [Abstract][Full Text] [Related]
18. Nigrostriatal and Mesolimbic D
Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
[TBL] [Abstract][Full Text] [Related]
19. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
[TBL] [Abstract][Full Text] [Related]
20. The role of striatal dopamine D
Veselinović T; Vernaleken I; Janouschek H; Cumming P; Paulzen M; Mottaghy FM; Gründer G
Psychopharmacology (Berl); 2018 Aug; 235(8):2221-2232. PubMed ID: 29717334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
